[go: up one dir, main page]

WO2008103751A3 - Thérapies et compositions antimicrobiennes et anti-inflammatoires - Google Patents

Thérapies et compositions antimicrobiennes et anti-inflammatoires Download PDF

Info

Publication number
WO2008103751A3
WO2008103751A3 PCT/US2008/054453 US2008054453W WO2008103751A3 WO 2008103751 A3 WO2008103751 A3 WO 2008103751A3 US 2008054453 W US2008054453 W US 2008054453W WO 2008103751 A3 WO2008103751 A3 WO 2008103751A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
delta
antimicrobial
haemolysin
inflammatory therapies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/054453
Other languages
English (en)
Other versions
WO2008103751A2 (fr
Inventor
Richard Gallo
Victor Nizet
Anna Cogen
Yuping Lai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Priority to US12/528,074 priority Critical patent/US20100166708A1/en
Publication of WO2008103751A2 publication Critical patent/WO2008103751A2/fr
Publication of WO2008103751A3 publication Critical patent/WO2008103751A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne des procédés et des compositions utiles pour le traitement d'infections microbiennes et virales. Sous certains aspects, les compositions et les procédés concernent l'utilisation d'une quantité efficace d'une delta-hémolysine et/ou d'une moduline-delta soluble dans le phénol ou d'une variante fonctionnelle de celles-ci. Sous d'autres aspects, les compositions et procédés concernent l'utilisation d'une quantité efficace de Staphylococcus epidermidis ou d'un extrait de S. epidermidis comportant la delta-hémolysine et/ou la moduline-delta soluble dans le phénol ou une variante fonctionnelle de celles-ci.
PCT/US2008/054453 2007-02-20 2008-02-20 Thérapies et compositions antimicrobiennes et anti-inflammatoires Ceased WO2008103751A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/528,074 US20100166708A1 (en) 2007-02-20 2008-02-20 Antimicrobial and anti-inflammatory therapies and compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89068307P 2007-02-20 2007-02-20
US60/890,683 2007-02-20

Publications (2)

Publication Number Publication Date
WO2008103751A2 WO2008103751A2 (fr) 2008-08-28
WO2008103751A3 true WO2008103751A3 (fr) 2008-12-31

Family

ID=39710724

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/054453 Ceased WO2008103751A2 (fr) 2007-02-20 2008-02-20 Thérapies et compositions antimicrobiennes et anti-inflammatoires

Country Status (2)

Country Link
US (1) US20100166708A1 (fr)
WO (1) WO2008103751A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2178904B1 (fr) 2007-06-06 2016-11-02 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Peptides psm comme cibles de vaccins contre le staphylocoque doré résistant à la méthicilline
EP2374813A1 (fr) * 2008-12-03 2011-10-12 Proyecto de Biomedicina Cima, S.L. Utilisation de modulines phénol-solubles pour le développement de vaccins
US11198724B2 (en) * 2013-03-14 2021-12-14 The Regents Of The University Of Michigan Treatment of staphylococcal disorders
CA2934769C (fr) * 2013-12-23 2019-09-24 Bruker Daltonik Gmbh Identification de staphylococcus aureus resistant a la methicilline (sarm)
KR102624665B1 (ko) * 2015-05-05 2024-01-12 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 항균 요법
US11028141B2 (en) * 2016-11-09 2021-06-08 Baylor College Of Medicine Therapeutic for the prevention and/or treatment of weight gain and/or diabetes
EP3538118B1 (fr) 2016-11-11 2021-03-03 Sjaellands Universitetshospital Dermatologisk Afdeling Bactéries saprophytes vivantes destinées à être utilisées dans le traitement de l'hidrosadénite suppurée
US10799520B2 (en) 2017-03-17 2020-10-13 Northwestern University Lipotechoic acid for immune modulation
KR102483977B1 (ko) * 2019-10-02 2023-01-04 주식회사 바이오미 면역 증강 활성 및 병원성 세균에 대한 항균 활성을 갖는 스타필로코커스 에피데르미데스 균주 및 이의 용도
US12370235B2 (en) 2021-03-04 2025-07-29 University Of Saskatchewan Synthetic, non-natural antimicrobial peptides inspired by Staphylococcus auricularis delta toxin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020121A (en) * 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482680A (en) * 1981-09-15 1984-11-13 Dynapol Quaternary ammonium group-containing polymers having antimicrobial activity
US5618675A (en) * 1992-07-16 1997-04-08 Panorama Research, Inc. Methods and compositions for detecting lipopolysaccharides using CAP18 fragments
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
JP4037525B2 (ja) * 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
US20040087559A1 (en) * 2000-09-22 2004-05-06 Schwartz Gary G. Methods for prevention and treatment of cancer
AU2002240137A1 (en) * 2001-01-30 2002-08-12 University Of Iowa Research Foundation Antiviral activities of primate theta defensins and mammalian cathelicidins
AU2003288507A1 (en) * 2002-12-19 2004-07-14 Yitzchak Hillman Disease treatment via antimicrobial peptide inhibitors
SE0300207D0 (sv) * 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
US7777000B2 (en) * 2003-03-06 2010-08-17 The Regents Of The University Of California Anti-viral activity of cathelicidin peptides
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) * 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
WO2005040192A2 (fr) * 2003-10-21 2005-05-06 The Regents Of The University Of California Peptides antimicrobiens de la cathelidicine humaine
US20090318534A1 (en) * 2006-09-27 2009-12-24 The Regents Of The University Of California Methods and compositions for the treatment of skin diseases and disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020121A (en) * 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KREGER A.S. ET AL.: "Purification and Properties of Staphylococcal Delta Hemolysin", INFECTION AND IMMUNITY, vol. 3, no. 3, March 1971 (1971-03-01), pages 449 - 465, XP002432722 *
LILES W.C. ET AL.: "Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 70, July 2001 (2001-07-01), pages 96 - 102, XP002577936 *
MEHLIN C. ET AL.: "An Inflammatory Polypeptide Complex from Staphylococcus epidermidis; Isolation and Characterization", J. EXP. MED., vol. 189, no. 6, 15 March 1999 (1999-03-15), pages 907 - 917, XP002577937 *

Also Published As

Publication number Publication date
US20100166708A1 (en) 2010-07-01
WO2008103751A2 (fr) 2008-08-28

Similar Documents

Publication Publication Date Title
WO2008103751A3 (fr) Thérapies et compositions antimicrobiennes et anti-inflammatoires
WO2011030158A3 (fr) Composition antimicrobienne
WO2008085578A3 (fr) Compositions et dispositifs antimicrobiens et procédés d'utilisation de ceux-ci
WO2008030988A3 (fr) Peptides antimicrobiens ciblés sélectivement et leur utilisation
WO2007085852A3 (fr) Matieres antimicrobiennes
WO2008153610A3 (fr) Utilisation d'antagonistes de il-23 pour le traitement d'une infection
EP4512475A3 (fr) Compositions comprenant un inhibiteur de l'arn polymerase et de la cyclodextrine pour le traitement d'infections virales
WO2007130655A3 (fr) Activités antimicrobiennes dérivées de bactériophages
WO2008010188A3 (fr) Compositions antimicrobiennes et pesticides et procédés correspondants, comprenant de l'huile à monoterpènes réduites extraite des myrtaceae
WO2008115281A3 (fr) Composés de traitement d'infections virales
WO2010004433A3 (fr) Aminoglycosides améliorés au plan de l'hydrophobicité
EP2279662A3 (fr) 5,7,4'-trihydroxy-3',5'-diméthoxyflavone comme agent antibactérien
MX2009009948A (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa.
WO2006013441A3 (fr) Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau
WO2011140310A3 (fr) Composition topique comprenant de la povidone iodée
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
WO2009062112A3 (fr) Utilisation d'inhibiteurs de récepteurs tam en tant qu'antimicrobiens
WO2008082692A3 (fr) Composés d'isothiocyanate, compositions pharmaceutiques, et leurs utilisations
WO2008083256A3 (fr) Compositions ophtalmiques et otiques de polymères et oligomères à face amphiphile et leurs utilisations
WO2008141010A3 (fr) Inhibiteurs de pompes à efflux bactériennes polybasiques et leurs utilisations thérapeutiques
WO2007098135A3 (fr) Compositions antimicrobiennes
WO2011056545A3 (fr) Liquides ioniques antimicrobiens
WO2011047320A3 (fr) Composés anti-microbiens et procédés permettant de les fabriquer et de les utiliser
WO2007089612A3 (fr) Procédés et compositions pour le traitement et la prévention d'infections bactériennes
WO2008132021A3 (fr) Mélanges fongicides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08743506

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12528074

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 08743506

Country of ref document: EP

Kind code of ref document: A2